• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芬兰疾病遗传的分子背景。

Molecular background of the Finnish disease heritage.

作者信息

Peltonen L

机构信息

Department of Human Molecular Genetics, University of Helsinki, National Public Health Institute, Finland.

出版信息

Ann Med. 1997 Dec;29(6):553-6. doi: 10.3109/07853899709007481.

DOI:10.3109/07853899709007481
PMID:9562523
Abstract

Finland has a population with a history revealing features of founder effect, genetic drift and isolation. Relatively small founder populations have slowly inhabited a large country and internal isolates have developed within Finland. This is reflected even today in the regional enrichment of some diseases belonging to the Finnish disease heritage. This concept was launched before the DNA era by skillful clinicians and today it comprises some 30 diseases with a wide variety of clinical phenotypes. Special strategies have been adapted in the initial locus assignment and in the restriction of the critical chromosomal DNA region having so far resulted in the successful isolation of 11 disease genes. Detailed analyses of these disease genes and their function have provided new insights into the structure and function of defective proteins as well as into the biology of affected tissues.

摘要

芬兰人口的历史呈现出奠基者效应、基因漂变和隔离的特征。相对较小的奠基者群体逐渐在这个大国定居下来,芬兰国内也形成了一些隔离群体。即便在今天,这一点仍体现在属于芬兰疾病遗传范畴的某些疾病在区域上的富集。这一概念是由技艺精湛的临床医生在DNA时代之前提出的,如今它涵盖了约30种具有广泛临床表型的疾病。在最初的基因定位以及关键染色体DNA区域的限定方面采用了特殊策略,目前已成功分离出11个疾病基因。对这些疾病基因及其功能的详细分析,为缺陷蛋白的结构和功能以及受影响组织的生物学特性提供了新的见解。

相似文献

1
Molecular background of the Finnish disease heritage.芬兰疾病遗传的分子背景。
Ann Med. 1997 Dec;29(6):553-6. doi: 10.3109/07853899709007481.
2
Molecular genetics of the Finnish disease heritage.芬兰疾病遗传的分子遗传学
Hum Mol Genet. 1999;8(10):1913-23. doi: 10.1093/hmg/8.10.1913.
3
Messages from an isolate: lessons from the Finnish gene pool.一个分离株的信息:来自芬兰基因库的经验教训。
Biol Chem Hoppe Seyler. 1995 Dec;376(12):697-704. doi: 10.1515/bchm3.1995.376.12.697.
4
Antenatal gene tests in low-risk pregnancies: molecular screening for aspartylglucosaminuria (AGU) and infantile neuronal ceroid lipofuscinosis (INCL) in Finland.
Prenat Diagn. 2001 May;21(5):409-12. doi: 10.1002/pd.82.
5
[Finnish disease heritage].[芬兰疾病遗传特征]
Duodecim. 2010;126(19):2311-20.
6
Mutations causing aspartylglucosaminuria (AGU): a lysosomal accumulation disease.导致天冬氨酰葡糖胺尿症(AGU)的突变:一种溶酶体贮积病。
Hum Mutat. 1992;1(5):361-5. doi: 10.1002/humu.1380010503.
7
Progressive nature of aspartylglucosaminuria.天冬氨酰葡糖胺尿症的进行性本质。
Acta Paediatr. 2002;91(3):255-7. doi: 10.1080/08035250252833842.
8
[The Anders Annual Prize for young researchers 1992. Identification of genes in human diseases].[1992年安德斯青年研究人员年度奖。人类疾病相关基因的鉴定]
Nord Med. 1993;108(2):40-1.
9
Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: application to aspartylglucosaminuria in Finland.使用固相微测序法便捷定量测定突变等位基因频率:在芬兰天冬氨酰葡糖胺尿症中的应用
Genomics. 1992 Mar;12(3):590-5. doi: 10.1016/0888-7543(92)90452-x.
10
Identification of a novel mutation causing aspartylglucosaminuria reveals a mutation hotspot region in the aspartylglucosaminidase gene.一种导致天冬氨酰葡糖胺尿症的新型突变的鉴定揭示了天冬氨酰葡糖胺酶基因中的一个突变热点区域。
Hum Mutat. 1995;5(4):318-26. doi: 10.1002/humu.1380050408.

引用本文的文献

1
Repeat Variants, Biomarkers, and Molecular Signatures in Parkinson's Disease: , , , , , , , , and -A Swedish Perspective.帕金森病中的重复变异、生物标志物与分子特征:瑞典视角
Int J Mol Sci. 2025 Sep 20;26(18):9213. doi: 10.3390/ijms26189213.
2
Causal relationship between gut microbiota and tuberculosis: a bidirectional two-sample Mendelian randomization analysis.肠道微生物群与结核病之间的因果关系:双向两样本孟德尔随机化分析。
Respir Res. 2024 Jan 4;25(1):16. doi: 10.1186/s12931-023-02652-7.
3
The Finnish genetic heritage in 2022 - from diagnosis to translational research.
2022 年的芬兰基因遗传 - 从诊断到转化研究。
Dis Model Mech. 2022 Oct 1;15(10). doi: 10.1242/dmm.049490. Epub 2022 Oct 26.
4
Rare non-coding variants are associated with plasma lipid traits in a founder population.在一个奠基人群体中,罕见的非编码变异与血浆脂质特征相关。
Sci Rep. 2017 Nov 27;7(1):16415. doi: 10.1038/s41598-017-16550-8.
5
Aspartylglycosaminuria: a review.天冬氨酰氨基葡糖苷尿症:综述
Orphanet J Rare Dis. 2016 Dec 1;11(1):162. doi: 10.1186/s13023-016-0544-6.
6
High mammographic density in women of Ashkenazi Jewish descent.阿什肯纳兹犹太裔女性的乳腺钼靶密度高。
Breast Cancer Res. 2013 May 13;15(3):R40. doi: 10.1186/bcr3424.
7
A population-based study of autosomal-recessive disease-causing mutations in a founder population.基于人群的研究在一个创始人群体中常染色体隐性疾病致病突变。
Am J Hum Genet. 2012 Oct 5;91(4):608-20. doi: 10.1016/j.ajhg.2012.08.007. Epub 2012 Sep 13.
8
The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: Mutational hot-spot or founder effect?家族性孤立性垂体腺瘤中芳香烃受体相互作用蛋白基因的 R304X 突变:突变热点还是起源效应?
J Endocrinol Invest. 2010 Dec;33(11):800-5. doi: 10.1007/BF03350345. Epub 2010 Mar 30.
9
Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance.对芬兰1546个前列腺癌家族进行的分离分析显示为隐性遗传。
Hum Genet. 2007 Apr;121(2):257-67. doi: 10.1007/s00439-006-0310-2. Epub 2007 Jan 3.
10
Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus.芬兰的遗传性前列腺癌:精细定位验证3p26为主要易感基因座。
Hum Genet. 2005 Jan;116(1-2):43-50. doi: 10.1007/s00439-004-1214-7. Epub 2004 Nov 11.